Skip to content
Disclosery

EXANE DERIVATIVES: ENPH position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on ENPH, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 1,317 ENPH shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 1,317 shares
    Change vs previous 13F -1,545 shares

    0.15% of the 13F portfolio, value $257,079.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 2,862 shares
    Change vs previous 13F +371 shares

    0.16% of the 13F portfolio, value $577,459.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 2,491 shares
    Change vs previous 13F +738 shares

    0.11% of the 13F portfolio, value $455,687.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 1,753 shares
    Change vs previous 13F -12 shares

    0.07% of the 13F portfolio, value $262,888.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 1,765 shares
    Change vs previous 13F +65 shares

    0.08% of the 13F portfolio, value $324,858.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 1,700 shares
    Change vs previous 13F -875 shares

    0.08% of the 13F portfolio, value $275,660.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 2,575 shares
    Change vs previous 13F not available

    0.14% of the 13F portfolio, value $451,814.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).